- Identification
- Properties
- Safety Data
- Specifications & Other Information
- Links
- Quick Inquiry
Identification
CAS Number
461432-26-8
Name
Dapagliflozin
Synonyms
(1S)-1,5-Anhydro-1-[4-chlor-3-(4-ethoxybenzyl)phenyl]-D-glucitol [German] [ACD/IUPAC Name]
(1S)-1,5-Anhydro-1-[4-chloro-3-(4-ethoxybenzyl)phenyl]-D-glucitol [ACD/IUPAC Name]
(1S)-1,5-Anhydro-1-[4-chloro-3-(4-éthoxybenzyl)phényl]-D-glucitol [French] [ACD/IUPAC Name]
(2S,3R,4R,5S,6R)-2-[4-chloro-3-(4-ethoxybenzyl)phenyl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
(2S,3R,4R,5S,6R)-2-{4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl}-6-(hydroxymethyl)oxane-3,4,5-triol
1ULL0QJ8UC
461432-26-8 [RN]
Dapagliflozin [INN] [USAN] [Wiki]
dapagliflozina [Spanish] [INN]
dapagliflozine [French] [INN]
dapagliflozinum [Latin] [INN]
D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)- [ACD/Index Name]
Farxiga [Trade name]
Forxiga [Trade name]
(1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol
(1S)-1,5-anhydro-1-c-4-chloro-3-(4-ethoxyphenyl)methylphenyl-d-glucitol
(2S,3R,4R,5S,6R)-2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol
(2S,3R,4R,5S,6R)-2-(3-(4-Ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyl-tetrahydro-2H-pyran-3,4,5-triol
(2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6- (hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
(2S,3R,4R,5S,6R)-2-[4-chloro-3-(4-ethoxybenzyl)phenyl]-6-methylol-tetrahydropyran-3,4,5-triol
(2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol
(2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
(2S,3R,4R,5S,6R)-2-4-chloro-3-(4-ethoxybenzyl)phenyl-6-(hyd roxymethyl)-tetrahydro-2H-pyran-3,4,5-triol
(2S,3R,4R,5S,6R)-2-4-chloro-3-(4-ethoxybenzyl)phenyl-6-(hydroxymethyl)tetrahy
(2S,4R,5R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxyMethyl)tetrahydro-2H-pyran-3,4,5-triol
[461432-26-8] [RN]
1204219-80-6 [RN]
BMS 512148
BMS 512148 ; BMS-512148
BMS512148
BMS-512148 ;BMS512148 ;BMS 512148
BMS-512148|Farxiga®|Forxiga®
dapagliflozin ????????????
dapagliflozin d5
dapagliflozin 达格列净 [Chinese]
Dapagliflozin ;BMS 512148
Dapagliflozin|BMS 512148
dapagliflozin-d5
Farxiga®
Forxiga®
https://www.ebi.ac.uk/chembl/compoundreportcard/CHEMBL429910/
MFCD13182359 [MDL number]
UNII :1ULL0QJ8UC
UNII-1ULL0QJ8UC
SMILES
CCOc1ccc(cc1)Cc2cc(ccc2Cl)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O
StdInChI
InChI=1S/C21H25ClO6/c1-2-27-15-6-3-12(4-7-15)9-14-10-13(5-8-16(14)22)21-20(26)19(25)18(24)17(11-23)28-21/h3-8,10,17-21,23-26H,2,9,11H2,1H3/t17-,18-,19+,20-,21+/m1/s1
StdInChIKey
JVHXJTBJCFBINQ-ADAARDCZSA-N
Molecular Formula
C21H25ClO6
Molecular Weight
408.873
EINECS
639-683-0
MDL Number
MFCD13182359
Properties
Appearance
white to grayish white powder
Structure
Structure of Dapagliflozin CAS 461432-26-8
Safety Data
Symbol
GHS07, GHS08, GHS09Signal Word
Warning
Hazard statements
H302 – H319 – H372 – H411Precautionary Statements
P260 – P264 – P273 – P301 + P312 – P305 + P351 + P338 – P314WGK Germany
3
MSDS Download
Specifications and Other Information of Our
Identification Methods
Heavy Metals
NMT 10ppm
Water
NMT 2%
Residue on Ignition
NMT 0.5%
Shelf Life
2 years
Storage
Known Application
Dapagliflozin is a sodium-glucose co-transporter 2 inhibitor (SGLT2i) and a new type of oral hypoglycemic drug. It can inhibit SGLT2 activity, inhibit proximal renal tubular sodium-glucose reabsorption, promote urinary glucose excretion, and thereby reduce blood glucose concentration.
General View of Documents
Links
This product is developed by our R&D company Caming Pharmaceutical Limited (http://www.caming.com/).
Quick Inquiry
Fill out our inquiry form and one of our experts will be in touch with you shortly.